🚨Final Registration Deadline Fast Approaching🚨 Make sure to register before Thursday 16th April 2026 to secure you place at the conference! Click here to register: bit.ly/4cXozKg #CancerImmuno #FusionImmunology #FusionCancerResearch

PhD students of the lab presenting their work on #glioblastoma and #antiangiogenic immune checkpoint inhibition, at @kuleuvenuniversity.bsky.social #Oncoforum at Gasthuisberg. Well done!

Don't forget to register - only one week left!

VIB Training & Conferences@vibtrainconf.bsky.social · last yr.

🕛 You have until the 23rd of April to register for #INCI25. After that, you will miss the latest #cancerbiology and #immunotherapy research developments. Claim your spot & see you in beautiful Bruges while there’s still time: vibbio.tech/4ic2SEZ #CancerBiology #Immunology #immunotherapy

Happening TODAY! #EVBOSeminarSeries Moderated by Agnes Nöel. Speakers: Gabriele Bergers and Sabine Bailly. ⏰When: Thursday 17th April 2025, 3PM EU time (2PM UK). Place: online. See you there! For registration evbo.org

📢We are hiring a postdoctoral researcher 📢 Are your curious about the mechanisms driving metastatic spread? Do you have *bioinformatics* skills to help us unravel these mechanisms? We (Scheelelab & Bergerslab) may have your dream job @viblifesciences.bsky.social VIB Center for Cancer Biology

Postdoctoral position in Bio-Informatics to unravel the metastatic journey in time and space - VIB

When cancer cells leave the primary tumor to seed in other organs, they need to seek the help of different cell types in distinct environments to make their journey successful. Lymph nodes (LN), which...

jobso.id

Are you ready for your next step in immunology/vascular biology research? Do you want to decipher the generation and function of tertiary lymphoid structures in cancer and chronic inflammation? Then check out our job opening for a postdoc position at the VIB Center for cancer Biology: jobso.id/k7ap

Postdoctoral position to study tertiary lymphoid structures in space and time - VIB

We have discovered that vascular/immunomodulating therapies can transform immunosuppressive tumor endothelial cells into immune-stimulating high-endothelial venules (HEV) that due to their specific fu...

jobso.id